Category - Executive Moves

Executive Moves

Canopy Growth names Mike Lee as acting CFO

Canopy Growth (TSX:WEED; NYSE:CGC) appointed Mike Lee as acting CFO, effective June 1, and subject to Health Canada security clearance required for all officers and directors of the company.

May 21, 2019

Executive Moves

Zenabis provides operational update; appoints Natascha Kiernan to board

Zenabis Global (TSXV:ZENA) provide an update on its recent cannabis production figures, anticipated future harvests, facility construction and licensing status, and medical program update.

May 21, 2019

Executive Moves

Neptune Wellness names Martin Landry as chief of corporate development and strategy

Neptune Wellness Solutions (NASDAQ:NEPT; TSX:NEPT) appointed Martin Landry to the new position of chief of corporate development and strategy, effective May 27.

May 14, 2019

Executive Moves

IntelGenx names André Godin to additional post of president

IntelGenx Technologies (TSXV:IGX; OTCQX:IGXT) appointed André Godin to the additional position of president. He continues as CFO and will continue to report to CEO, Dr. Horst Zerbe.

May 9, 2019

Executive Moves

MediPharm names Braden Fenske as chief strategy officer, Dr. Paul Tam as director

MediPharm Labs (TSXV:LABS; OTCQB:MEDIF) appointed Braden Fenske as chief strategy officer and Dr. Paul Tam to its board of directors, effective immediately.

May 1, 2019

Executive Moves

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) named Dr. Ashish Kamat to its scientific advisory board.

April 17, 2019

Executive Moves

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board.

April 12, 2019

Executive Moves

Wedbush names Laura Chico as SVP of healthcare equity research

Wedbush Securities appointed Laura Chico, SVP of equity research on the healthcare and biotech team.

April 2, 2019

Executive Moves

iBio names industry veteran Thomas Isett to board

iBio (NYSE AMERICAN:IBIO) appointed Thomas Isett as a director, effective immediately.

April 1, 2019

Executive Moves

Celyad promotes Filippo Petti to CEO

Celyad SA (NASDAQ:CYAD) of Belgium named Filippo Petti, currently CFO, to the post of CEO, effective April 1, 2019.

March 29, 2019

Category - Executive Moves

Canopy Growth names Mike Lee as acting CFO

Zenabis provides operational update; appoints Natascha Kiernan to board

Neptune Wellness names Martin Landry as chief of corporate development and strategy

IntelGenx names André Godin to additional post of president

MediPharm names Braden Fenske as chief strategy officer, Dr. Paul Tam as director

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Wedbush names Laura Chico as SVP of healthcare equity research

iBio names industry veteran Thomas Isett to board

Celyad promotes Filippo Petti to CEO

General

More